Magnetic Barcode Beads for Multiplexed SARS-CoV-2 Antibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting COVID-19 antibodies, such as ELISA and LFIA, are limited by low sensitivity, specificity, and the inability to multiplex tests for multiple virus variants, making it difficult to analyze humoral immunity against COVID-19 variants effectively.
Innovation Solution
The use of magnetic barcode beads conjugated with receptor binding domain (RBD) or nucleocapsid protein (N protein) from wild-type SARS-CoV-2 and variants, combined with a barcode bead fluorescence reader that utilizes visible light, such as LEDs, to distinguish and quantify the beads, enabling high-throughput, multiplexed antibody detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ELISA is used for antibody detection, then sensitivity is improved, but the ability to detect multiple virus strains simultaneously deteriorates
Solution Approach 1:
The invention segments the detection system by using magnetic beads with distinct two-dimensional edge patterns, where each bead type represents a different virus strain. This segmentation allows parallel detection of multiple strains while maintaining the sensitivity of individual assays, directly resolving the contradiction between sensitivity and multiplexing capability.
Solution Approach 2:
The magnetic bead platform serves multiple functions: it maintains high detection sensitivity like ELISA while simultaneously enabling multiplexed detection of multiple virus strains. The universal bead-based system can detect various strains in a single assay, making the system multi-functional and resolving the trade-off between sensitivity and versatility.
2Productivity
If protein microarray is used for high-throughput detection, then productivity is improved, but device complexity and manual operation increase
Solution Approach 1:
The invention replaces the complex mechanical alignment system of protein microarrays with a simpler magnetic bead-based system. The two-dimensional edge patterns on magnetic beads enable automatic identification and quantification without complex mechanical alignment, reducing device complexity while maintaining high throughput capability.
Solution Approach 2:
The invention changes the identification parameter from spatial position (requiring complex alignment) to optical/physical properties of magnetic beads (edge patterns). This parameter change simplifies the system by eliminating the need for precise mechanical alignment while preserving high-throughput detection capability.
3Ease of operation
If conventional antibody detection methods are used, then ease of operation is maintained, but measurement precision and ability to distinguish variants deteriorates
Solution Approach 1:
The invention uses distinct two-dimensional edge patterns on magnetic beads that can be detected by a reader system. These visual/physical differences in bead patterns enable precise variant discrimination while maintaining ease of operation, as the automated reader handles the complex identification without requiring manual intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides an automatic, time-saving, low-cost, high-sensitivity, and high-throughput method for measuring antibody levels against multiple SARS-CoV-2 variants, allowing for the evaluation of vaccine protection, classification of COVID-19 severity, and differentiation between vaccinated and infected individuals.
Implementation Method 1
a barcode bead fluorescence reader that utilizes visible light, such as LEDs, to distinguish and quantify the beads
Data Source
AI summary
A detection agent, a detection system, and a method thereof are provided. The detection agent includes magnetic barcode beads. Each of the magnetic barcode beads has different two-dimensional edge and is conjugated with a corresponding protein. The protein includes a receptor binding domain of a spike protein or a nucleocapsid protein from a virus or a variant of the virus. The detection system includes the detection agent and a barcode bead fluorescence reader to read a fluorescence signal generated by each of the magnetic barcode beads. The method includes the steps of adding a serum of the subject to the detection agent followed by adding a fluorescently labeled anti-human immunoglobulin antibody and reading a fluorescence signal generated by each of the magnetic barcode beads and discriminating each of the magnetic barcode beads by the barcode bead fluorescence reader to quantify the anti-human immunoglobulin antibody.